RESUMEN
Seminal vesicles can be affected by tumours originating in other locations. However, primary tumours of the seminal vesicle are extremely rare, with less than 100 cases reported in literature. Seminal vesicle adenocarcinoma is the most common type, but there are also other malign lesions. Diagnosis is challenging due to the lack of early symptoms and well-defined criteria. These tumours are usually asymptomatic and discovered incidentally during imaging tests or pelvic surgery. Definitive diagnosis requires anatomopathological analysis. Case report of 58-years-old man with schwannoma of the seminal vesicle. We describe the main characteristics of these tumours as well as their therapeutic approach.
RESUMEN
BACKGROUND: This study sought to document the safety of a new accelerated dobutamine-atropine stress echocardiography protocol and to analyze its complications. METHODS: Dobutamine-atropine stress echocardiography studies were performed using an incremental dobutamine infusion protocol from 20 to 40 microg/kg/min in 3-minute stages and followed by atropine. RESULTS: A total of 962 patients were included. Mean age was 64 +/- 11 years and 584 were male (61%). Mean ejection fraction was 62 +/- 10%. Complications included hypertensive responses in 66 patients (7%), arrhythmias in 26 (2.7%), and symptomatic hypotension in 16 (1.7%). No patient developed heart failure, acute myocardial infarction, ventricular fibrillation, or died. The independent predictors of hypertensive responses were age, baseline systolic blood pressure, and treatment with nitrates. The independent predictors of arrhythmias were history of hypertension, previous coronary artery disease, and baseline heart rate. CONCLUSIONS: This accelerated dobutamine-atropine stress echocardiography protocol is safe in a low-risk population and has a rate of complications similar to that reported for the standard protocol.
Asunto(s)
Agonistas Adrenérgicos beta , Atropina , Dobutamina , Ecocardiografía de Estrés , Antagonistas Muscarínicos , Agonistas Adrenérgicos beta/efectos adversos , Agonistas Adrenérgicos beta/farmacología , Anciano , Arritmias Cardíacas/complicaciones , Arritmias Cardíacas/fisiopatología , Atropina/efectos adversos , Atropina/farmacología , Presión Sanguínea , Dobutamina/efectos adversos , Dobutamina/farmacología , Relación Dosis-Respuesta a Droga , Evaluación de Medicamentos , Ecocardiografía , Electrocardiografía , Femenino , Cefalea/inducido químicamente , Humanos , Hipertensión/complicaciones , Hipertensión/fisiopatología , Hipotensión/complicaciones , Hipotensión/fisiopatología , Modelos Logísticos , Masculino , Persona de Mediana Edad , Antagonistas Muscarínicos/efectos adversos , Antagonistas Muscarínicos/farmacología , Náusea/inducido químicamente , Valor Predictivo de las Pruebas , Medición de Riesgo , Taquicardia Ventricular/inducido químicamente , Factores de Tiempo , Temblor/inducido químicamenteRESUMEN
Direct cardioversion used in the treatment of various cardiac arrhythmias is a highly effective and simple procedure with infrequent complications. An uncommon complication is the occurrence of pulmonary edema. This report describes a 68-year-old woman with normal coronary arteries who experienced pulmonary edema following cardioversion secondary to myocardial injury demonstrated by ECG changes and elevation of troponin T.